Mason, OH, September 22, 2021 – Benchmark Digital Partners (formerly Gensuite LLC) is happy to welcome Instil Bio into the Benchmark ESG™ | Gensuite® global subscriber group.
By implementing the Benchmark ESG™ | Gensuite® cloud-based Environmental, Social, Governance (ESG) software platform, Instil Bio will place an increased focus on the improvement of their compliance assurance program. In addition, the deployment of Benchmark’s software will enable employees and leadership to easily access equipment inventory and engage in the timely identification, reporting, and mitigation of safety concerns.
Instil Bio is a clinical-stage cell therapy company dedicated to bringing the promise of tumor infiltrating lymphocytes (TIL) to patients in need, by developing TIL for the treatment of cancer. Instil Bio’s manufacturing platform has been designed to enhance the logistics and accessibility of TIL therapy to build on the decades-long foundation of TIL in treating solid tumors.
To learn more about Benchmark ESG™ | Gensuite®, visit www.benchmarkdigitalesg.com. To learn more about Instil Bio, visit https://instilbio.com/.
About Benchmark ESG™| Gensuite®
Benchmark ESG™ | Gensuite® enables companies to implement robust cross-functional Environmental, Social, and Governance (ESG) Solutions – locally, globally and across diverse operating profiles. Our comprehensive cloud-based software suite features intuitive, best-practice process functionality, flexible configurations and powerful extensions. For over two decades, we’ve helped companies manage safe & sustainable operations worldwide, with a focus on fast return on investment (ROI), service excellence and continuous innovation. Join over 1,500,000 users that trust Benchmark ESG™ Powered by Gensuite® with their software system needs for operational risk and compliance, EHS, sustainability, product stewardship and responsible sourcing.
